104 related articles for article (PubMed ID: 1894582)
1. Interleukin-2: basic biology and therapeutic use.
Williams TM; Fox KR; Kant JA
Hematol Pathol; 1991; 5(2):45-55. PubMed ID: 1894582
[No Abstract] [Full Text] [Related]
2. [Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology].
Barón Saura JM; Pizarro Redondo A; Berrocal Jaime A; González Barón M
Rev Clin Esp; 1991 May; 188(9):468-72. PubMed ID: 1896596
[TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer lymphocytes: biotherapeutics clinical trials.
West WH
Immunol Ser; 1989; 48():79-92. PubMed ID: 2488327
[No Abstract] [Full Text] [Related]
4. Lymphokine-activated killer lymphocytes: extramural clinical trials.
Sniecinski IJ
Immunol Ser; 1989; 48():59-77. PubMed ID: 2488326
[No Abstract] [Full Text] [Related]
5. Therapy with interleukin-2 and tumor-derived activated lymphocytes.
Oldham RK
Immunol Ser; 1994; 61():251-71. PubMed ID: 8011748
[No Abstract] [Full Text] [Related]
6. Lymphokine-activated killer lymphocytes: National Cancer Institute clinical trials.
Clark J; Longo DL
Immunol Ser; 1989; 48():37-58. PubMed ID: 2488325
[No Abstract] [Full Text] [Related]
7. Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.
Blacklock JB; Grimm EA
Immunol Ser; 1989; 48():93-9. PubMed ID: 2488328
[No Abstract] [Full Text] [Related]
8. [Immunotherapy of malignant diseases using interleukin 2. Bases, results, trends].
Gause A; Pfreundschuh M
Med Klin (Munich); 1990 Sep; 85(9):561-6, 570. PubMed ID: 2233615
[No Abstract] [Full Text] [Related]
9. Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
Wolf JA; Grimm EA
Curr Opin Oncol; 1989 Dec; 1(2):249-57. PubMed ID: 2489968
[No Abstract] [Full Text] [Related]
10. Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.
Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
Cancer Res; 1991 Mar; 51(5):1494-8. PubMed ID: 1997188
[TBL] [Abstract][Full Text] [Related]
11. [Care of advanced tumor treated by interleukin-2 and lymphokine-activated killer cells].
Wu Y; Li LC
Zhonghua Hu Li Za Zhi; 1994 Nov; 29(11):654-6. PubMed ID: 7614584
[No Abstract] [Full Text] [Related]
12. Clinical/technical challenges in adoptive cellular immunotherapy: in vitro culture techniques.
Yannelli JR; Jadus MR; Beckner S; Lacerna LV; Oldham RK
Immunol Ser; 1989; 48():191-206. PubMed ID: 2488322
[No Abstract] [Full Text] [Related]
13. [Immunotherapy of malignant melanoma].
Flageul B; Miclea JM; Bensussan A; Degos L
Pathol Biol (Paris); 1990 Oct; 38(8):881-2. PubMed ID: 2274397
[No Abstract] [Full Text] [Related]
14. [Our experience with lymphocytes activated against cancer: CTL cells].
Marcellino LR; Vinciguerra M; Marcellino MV; Sessa E
G Chir; 1997 Oct; 18(10):605-7. PubMed ID: 9479972
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of interleukin-2 in treating cancer.
Patterson DL; Wiemann MC
Indiana Med; 1991 Aug; 84(8):534-7. PubMed ID: 1918915
[No Abstract] [Full Text] [Related]
16. Interleukin 2 in cancer therapy.
Testa U; Montesoro E; Bulgarini D; Samoggia P; Masciulli R; Habetswallner D; Carè A; Mariani G; Giannella G; Boccoli G
Ann Ist Super Sanita; 1990; 26(3-4):283-334. PubMed ID: 2091501
[TBL] [Abstract][Full Text] [Related]
17. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Sacchi M; Snyderman CH; Heo DS; Johnson JT; d'Amico F; Herberman RB; Whiteside TL
Cancer Res; 1990 May; 50(10):3113-8. PubMed ID: 2334906
[TBL] [Abstract][Full Text] [Related]
18. Adoptive cellular therapy.
Urba WJ; Longo DL
Cancer Chemother Biol Response Modif; 1990; 11():265-80. PubMed ID: 2223395
[No Abstract] [Full Text] [Related]
19. Augmentation of insulin autoantibodies following interleukin-2 and lymphokine activated killer cell therapy.
Bergstrom RW; Atkins MB; Mier JW; Palmer JP
J Clin Lab Immunol; 1990 Apr; 31(4):189-93. PubMed ID: 1967063
[TBL] [Abstract][Full Text] [Related]
20. [Adoptive immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes].
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH
Ned Tijdschr Geneeskd; 1989 Oct; 133(40):1994-5. PubMed ID: 2812087
[No Abstract] [Full Text] [Related]
[Next] [New Search]